CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

BACKGROUND AND OBJECTIVES: In the past decade, autologous hematopoietic stem cell transplantation (AHSCT) has emerged as a treatment for relapsing-remitting multiple sclerosis (RRMS). How this procedure affects biomarkers of B- and T-cell activation is currently unknown. The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundblad, Katarina, Zjukovskaja, Christina, Larsson, Anders, Cherif, Honar, Kultima, Kim, Burman, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265403/
https://www.ncbi.nlm.nih.gov/pubmed/37311645
http://dx.doi.org/10.1212/NXI.0000000000200135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265403/
https://www.ncbi.nlm.nih.gov/pubmed/37311645
http://dx.doi.org/10.1212/NXI.0000000000200135

Ejemplares similares